18422384. PROSTHETIC VALVES WITH MECHANISMS FOR CONTROLLED EXPANSION simplified abstract (EDWARDS LIFESCIENCES CORPORATION)

From WikiPatents
Jump to navigation Jump to search

PROSTHETIC VALVES WITH MECHANISMS FOR CONTROLLED EXPANSION

Organization Name

EDWARDS LIFESCIENCES CORPORATION

Inventor(s)

Noam Nir of Pardes-Hanna (IL)

Michael Bukin of Pardes Hanna (IL)

Ofir Witzman of Harish (IL)

Oren Cohen of Kadima (IL)

PROSTHETIC VALVES WITH MECHANISMS FOR CONTROLLED EXPANSION - A simplified explanation of the abstract

This abstract first appeared for US patent application 18422384 titled 'PROSTHETIC VALVES WITH MECHANISMS FOR CONTROLLED EXPANSION

Simplified Explanation

The patent application is for self-expanding prosthetic heart valves with resistance-based mechanisms to control the rate of self-expansion.

  • The prosthetic heart valve can radially self-expand to a partially expanded state before further expansion and locking in the fully expanded state.
  • Some valves can self-expand from a compressed state to fully expanded without mechanical actuation.
  • Resistance-based expansion control mechanisms are placed between delivery system actuators and valve frame components.

Potential Applications

The technology could be used in minimally invasive heart surgeries, improving the efficiency and accuracy of valve placement.

Problems Solved

This innovation addresses the need for precise control over the expansion of prosthetic heart valves during implantation procedures.

Benefits

The resistance-based mechanisms offer a reliable way to regulate the self-expansion process, reducing the risk of complications during surgery.

Potential Commercial Applications

"Revolutionizing Heart Valve Implantation with Self-Expanding Technology"

Possible Prior Art

There may be prior art related to self-expanding prosthetic heart valves, but specific examples are not provided in this abstract.

Unanswered Questions

How does this technology compare to traditional prosthetic heart valves in terms of long-term effectiveness and patient outcomes?

This article does not provide information on the long-term effectiveness or patient outcomes associated with the use of self-expanding prosthetic heart valves. Further research or clinical studies may be needed to determine how this technology compares to traditional valves in these aspects.

What are the potential limitations or drawbacks of using resistance-based mechanisms to control the rate of self-expansion in prosthetic heart valves?

The abstract does not discuss any potential limitations or drawbacks of this technology. It would be important to consider factors such as device reliability, cost-effectiveness, and compatibility with different patient anatomies when evaluating the practicality of implementing resistance-based mechanisms in prosthetic heart valves.


Original Abstract Submitted

This disclosure is directed to self-expanding prosthetic heart valves having resistance-based mechanisms to control the rate of self-expansion of the prosthetic heart valves. In some examples, the prosthetic heart valve can be configured to radially self-expand to a partially radially expanded state, and can then be further radially expanded to the radially expanded state and/or locked in the radially expanded state by pulling an actuation member of the expansion and locking assembly. In other examples, the prosthetic heart valve can be configured to self-expand from the radially compressed state to the fully radially expanded state without mechanical actuation. In some examples, the resistance-based expansion control mechanisms can be disposed between delivery system actuators and valve frame components. In other examples, the resistance-based expansion control mechanisms can be disposed between delivery system actuators and other components of the delivery system.